Report ID: PMRREP34676
Number of Pages: 195
Format: PPT*, PDF, EXCEL
Industry: Healthcare
Published Date: August-2024
1. Executive Summary
1.1. Global Hydrogel-based Drug Delivery System Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Epidemiology - Prevalence and Incidence of Target Diseases
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter's Five Force Analysis
4. Global Hydrogel-based Drug Delivery System Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
4.1. Key Highlights
4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Mn) Analysis, 2018-2022
4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023-2031
4.3. Global Hydrogel-based Drug Delivery System Market Outlook: Polymer Origin
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Polymer Origin, 2018 - 2022
4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Origin, 2023 - 2031
4.3.3.1. Natural
4.3.3.2. Synthetic
4.3.3.3. Hybrid
4.4. Market Attractiveness Analysis: Polymer Origin
4.5. Global Hydrogel-based Drug Delivery System Market Outlook: Delivery Route
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Mn) Analysis, By Delivery Route, 2018 - 2022
4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Delivery Route, 2023 - 2031
4.5.3.1. Subcutaneous
4.5.3.2. Oral Cavity
4.5.3.3. Ocular
4.5.3.4. Topical
4.5.3.5. Others
4.6. Market Attractiveness Analysis: Delivery Route
4.7. Global Hydrogel-based Drug Delivery System Market Outlook: Distribution Channel
4.7.1. Introduction / Key Findings
4.7.2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2018 - 2022
4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
4.7.3.1. Hospitals
4.7.3.2. Specialty Clinics
4.7.3.3. Diagnostic Centres
4.7.3.4. Research and Academic Institutes
4.8. Market Attractiveness Analysis: Distribution Channel
5. Global Hydrogel-based Drug Delivery System Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2018 - 2022
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2023 - 2031
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Hydrogel-based Drug Delivery System Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
6.2.1. By Country
6.2.2. By Polymer Origin
6.2.3. By Delivery Route
6.2.4. By Distribution Channel
6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Origin, 2023 - 2031
6.4.1. Natural
6.4.2. Synthetic
6.4.3. Hybrid
6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Delivery Route, 2023 - 2031
6.5.1. Subcutaneous
6.5.2. Oral Cavity
6.5.3. Ocular
6.5.4. Topical
6.5.5. Others
6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
6.6.1. Hospitals
6.6.2. Specialty Clinics
6.6.3. Retail Pharmacy Chains
6.6.4. Drug Stores
6.6.5. Online Sales Channel
6.7. Market Attractiveness Analysis
7. Europe Hydrogel-based Drug Delivery System Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
7.2.1. By Country
7.2.2. By Polymer Origin
7.2.3. By Delivery Route
7.2.4. By Distribution Channel
7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Türkiye
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Origin, 2023 - 2031
7.4.1. Natural
7.4.2. Synthetic
7.4.3. Hybrid
7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Delivery Route, 2023 - 2031
7.5.1. Subcutaneous
7.5.2. Oral Cavity
7.5.3. Ocular
7.5.4. Topical
7.5.5. Others
7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
7.6.1. Hospitals
7.6.2. Specialty Clinics
7.6.3. Retail Pharmacy Chains
7.6.4. Drug Stores
7.6.5. Online Sales Channel
7.7. Market Attractiveness Analysis
8. East Asia Hydrogel-based Drug Delivery System Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
8.2.1. By Country
8.2.2. By Polymer Origin
8.2.3. By Delivery Route
8.2.4. By Distribution Channel
8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Origin, 2023 - 2031
8.4.1. Natural
8.4.2. Synthetic
8.4.3. Hybrid
8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Delivery Route, 2023 - 2031
8.5.1. Subcutaneous
8.5.2. Oral Cavity
8.5.3. Ocular
8.5.4. Topical
8.5.5. Others
8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
8.6.1. Hospitals
8.6.2. Specialty Clinics
8.6.3. Retail Pharmacy Chains
8.6.4. Drug Stores
8.6.5. Online Sales Channel
8.7. Market Attractiveness Analysis
9. South Asia & Oceania Hydrogel-based Drug Delivery System Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
9.2.1. By Country
9.2.2. By Polymer Origin
9.2.3. By Delivery Route
9.2.4. By Distribution Channel
9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Origin, 2023 - 2031
9.4.1. Natural
9.4.2. Synthetic
9.4.3. Hybrid
9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Delivery Route, 2023 - 2031
9.5.1. Subcutaneous
9.5.2. Oral Cavity
9.5.3. Ocular
9.5.4. Topical
9.5.5. Others
9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
9.6.1. Hospitals
9.6.2. Specialty Clinics
9.6.3. Retail Pharmacy Chains
9.6.4. Drug Stores
9.6.5. Online Sales Channel
9.7. Market Attractiveness Analysis
10. Latin America Hydrogel-based Drug Delivery System Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
10.2.1. By Country
10.2.2. By Polymer Origin
10.2.3. By Delivery Route
10.2.4. By Distribution Channel
10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Origin, 2023 - 2031
10.4.1. Natural
10.4.2. Synthetic
10.4.3. Hybrid
10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Delivery Route, 2023 - 2031
10.5.1. Subcutaneous
10.5.2. Oral Cavity
10.5.3. Ocular
10.5.4. Topical
10.5.5. Others
10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
10.6.1. Hospitals
10.6.2. Specialty Clinics
10.6.3. Retail Pharmacy Chains
10.6.4. Drug Stores
10.6.5. Online Sales Channel
10.7. Market Attractiveness Analysis
11. Middle East & Africa Hydrogel-based Drug Delivery System Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
11.2.1. By Country
11.2.2. By Polymer Origin
11.2.3. By Delivery Route
11.2.4. By Distribution Channel
11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Origin, 2023 - 2031
11.4.1. Natural
11.4.2. Synthetic
11.4.3. Hybrid
11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Delivery Route, 2023 - 2031
11.5.1. Subcutaneous
11.5.2. Oral Cavity
11.5.3. Ocular
11.5.4. Topical
11.5.5. Others
11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
11.6.1. Hospitals
11.6.2. Specialty Clinics
11.6.3. Retail Pharmacy Chains
11.6.4. Drug Stores
11.6.5. Online Sales Channel
11.7. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2023
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. GALDERMA
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Blairex Laboratories, Inc.
12.3.2.1. Overview
12.3.2.2. Segments and Products
12.3.2.3. Key Financials
12.3.2.4. Market Developments
12.3.2.5. Market Strategy
12.3.3. Johnson & Johnson
12.3.3.1. Overview
12.3.3.2. Segments and Products
12.3.3.3. Key Financials
12.3.3.4. Market Developments
12.3.3.5. Market Strategy
12.3.4. Bausch and Lomb
12.3.4.1. Overview
12.3.4.2. Segments and Products
12.3.4.3. Key Financials
12.3.4.4. Market Developments
12.3.4.5. Market Strategy
12.3.5. Medtronic
12.3.5.1. Overview
12.3.5.2. Segments and Products
12.3.5.3. Key Financials
12.3.5.4. Market Developments
12.3.5.5. Market Strategy
12.3.6. Ocular Therapeutix, Inc.
12.3.6.1. Overview
12.3.6.2. Segments and Products
12.3.6.3. Key Financials
12.3.6.4. Market Developments
12.3.6.5. Market Strategy
12.3.7. Ferring B.V.
12.3.7.1. Overview
12.3.7.2. Segments and Products
12.3.7.3. Key Financials
12.3.7.4. Market Developments
12.3.7.5. Market Strategy
12.3.8. Endo International plc
12.3.8.1. Overview
12.3.8.2. Segments and Products
12.3.8.3. Key Financials
12.3.8.4. Market Developments
12.3.8.5. Market Strategy
12.3.9. Akorn, Incorporated
12.3.9.1. Overview
12.3.9.2. Segments and Products
12.3.9.3. Key Financials
12.3.9.4. Market Developments
12.3.9.5. Market Strategy
12.3.10. Tolmar Pharmaceuticals, Inc
12.3.10.1. Overview
12.3.10.2. Segments and Products
12.3.10.3. Key Financials
12.3.10.4. Market Developments
12.3.10.5. Market Strategy
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
